CinDome Pharma Announces Enrollment Completion in the envision3D Phase 2 Clinical Trial of Deudomperidone (CIN-102) for the Treatment of Diabetic Gastroparesis
Deudomperidone represents the first potential therapeutic for the long-term treatment of gastroparesis.